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Large inter  individual variation has been 
observed in urinary mercury levels in the gen-
eral population and in workers after exposures 
of similar magnitudes to elemental mercury 
(Tsuji et al. 2003), and in hair mercury lev-
els in association with dietary fish consump-
tion (Canuel et al. 2006; Haxton et al. 1979). 
Variation was also seen in the elimination half-
life of methyl  mercury (MeHg) in humans, 
ranging from 45 to 70 days (Clarkson 2002).
Although variation in sources and levels of 
exposure may contribute to the overall inter-
individual variation in mercury biomarker 
levels, differences in mercury retention may 
also play an important role. Mercury reten-
tion may be influenced by changes in mercury 
binding by functional enzymes and proteins 
that transport, oxidize, and reduce mercury 
and its metabolites in humans (Gundacker 
et al. 2010). Single-nucleotide poly  morphisms 
(SNPs) in genes that encode the enzyme for the 
rate-limiting step in gluta  thione synthesis (glu-
tamate cysteine ligase) and that catalyze gluta-
thione conjugation [gluta  thione S-transferase 
(GST)] are associated with variability in 
mercury biomarker levels after exposures to 
MeHg or inorganic mercury (Custodio et al. 
2004, 2005; Gundacker et al. 2007, 2009; 
Schläwicke Engström et al. 2008).
Little is known about how poly  morphisms 
in genes encoding metallothioneins (MTs), a 
family of thiol-rich mercury-binding proteins, 
may affect mercury biomarker levels in humans. 
MT proteins actively bind heavy metals via 
thiol groups in cysteine residues and protect 
against heavy metal toxicity and oxidative stress 
in kidney, liver, and brain (Aschner et al. 2006; 
Kumari et al. 1998; Schurz et al. 2000; Yoshida 
et al. 1999). Humans express four primary MT 
isoforms (MT1, MT2, brain-specific MT3, 
and MT4). MT transcription levels could affect 
their mercury-binding capacity. SNPs located 
in regions important for regulating transcrip-
tion may have an impact on MT detoxifying 
capability, subsequently affecting mercury 
retention and altering biomarker levels.
Few studies have investigated the potential 
effect modification of MT SNPs on the 
relationship of urinary mercury levels with 
elemental mercury exposures. Gundacker et al. 
(2009) investigated the effects of MT SNPs on 
the association of MeHg exposure with hair 
mercury levels and found that subjects with the 
MT4 [rs11643815, dbSNP database (National 
Center for Biotechnology Information 2011)] 
GA or AA variant geno  type had lower hair 
mercury levels. The goal of the present study 
was to investigate whether SNPs in MT 
and MT transcription factor genes modify 
the relationships of elemental mercury and 
MeHg exposure with urinary and hair mercury 
levels, respectively. We sought to explain the 
considerable variation in biomarkers seen in 
subjects exposed to elemental mercury and 
MeHg of similar magnitudes by studying 
poly  morphisms in genes that play key roles in 
mercury toxico  kinetics.
Materials and Methods
Subjects were recruited during the Michigan 
Dental Association annual conventions held 
in 2009 (n = 232) and 2010 (n = 283), as 
previously described (Goodrich et al. 2011). 
They represent a convenience sample of dental 
professionals attending the conventions. All 
partici  pants provided written informed con-
sent. The study was approved by the University 
of Michigan Institutional Review Board.
Measurements of exposure. Each subject 
completed a self-administered questionnaire 
to provide information about recent mercury 
exposures from different sources, demo  graphic 
information, and covariates. Subjects reported 
elemental mercury exposures as average num-
ber of amalgams placed or removed per week 
(amalgams handled) and total number of 
dental amalgam restorations in their mouth 
(personal amalgam). We also surveyed MeHg 
exposure from dietary fish consumption within 
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Ba c k g r o u n d: Recent studies have suggested that several genes that mediate mercury metabolism 
are polymorphic in humans.
oB j e c t i v e: We hypothesized that single-nucleotide polymorphisms (SNPs) in metallothionein 
(MT) genes may under  lie inter  individual differences in mercury biomarker levels. We studied the 
potential modifying effects of MT SNPs on mercury exposure–biomarker relationships.
Me t h o d s : We measured total mercury in urine and hair samples of 515 dental professionals. We 
also surveyed occupational and personal exposures to dental amalgam and dietary fish consumption, 
from which daily methylmercury (MeHg) intake was estimated. Log-transformed urine and hair 
levels were modeled in multi  variable linear regression separately against respective exposure surro-
gates, and the effect modification of 13 MT SNPs on exposure was investigated.
re s u l t s: The mean mercury levels in urine (1.06 μg/L) and hair (0.51 μg/g) were not significantly 
different from the U.S. general population (0.95 μg/L and 0.47 μg/g, respectively). The mean 
estimated daily MeHg intake was 0.084 μg/kg/day (range, 0–0.98 μg/kg/day), with 25% of study 
population intakes exceeding the current U.S. Environmental Protection Agency reference dose of 
0.1 μg/kg/day. Multivariate regression analysis showed that subjects with the MT1M (rs2270837) 
AA geno  type (n = 10) or the MT2A (rs10636) CC geno  type (n = 42) had lower urinary mercury 
levels than did those with the MT1M or MT2A GG geno  type (n = 329 and 251, respectively) after 
controlling for exposure and potential confounders. After controlling for MeHg intake, subjects 
with MT1A (rs8052394) GA and GG geno  types (n = 24) or the MT1M (rs9936741) TT geno  type 
(n = 459) had lower hair mercury levels than did subjects with MT1A AA (n = 113) or MT1M TC 
and CC geno  types (n = 15), respectively. 
co n c l u s i o n: Our findings suggest that some MT genetic polymorphisms may influence mercury 
biomarker concentrations at levels of exposure relevant to the general population.
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the 6-month period before the date of the 
survey. We surveyed the average portion size 
and consumption frequency of 28 fish species 
[see Supplemental Material, Table 1 (http://
dx.doi.org/10.1289/ehp.1104079)], using a 
scheme adopted from the National Health and 
Nutrition Examination Survey (NHANES) 
Food Frequency Questionnaire (2003–2004) 
[Centers for Disease Control and Prevention 
(CDC) 2003]. We also obtained species-
specific average mercury concentrations (see 
Supplemental Material, Table 1). We esti-
mated daily MeHg intake (micrograms per 
kilogram per day) from dietary fish consump-
tion for each subject based on the formula 
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where U is the average unit portion size of fish 
meals (grams per portion); Pi is the frequency 
of eating a particular fish species (portions per 
month), with i = 1, 2, 3 . . . 28 species; Ci is 
the species-specific average MeHg concentra-
tion in fish tissues (micrograms per gram); 
BW is body weight of the subject (kilograms); 
and T is 30 days/month.
Other covariates. We classified partici-
pant job categories as dentist, hygienist, dental 
assistant, and other. Marketing managers or 
exhibitors, who do not have direct contact 
with mercury but are affiliated with a dental 
office or an organization, were categorized as 
“other.” We also obtained other covariates, 
including alcoholic beverage consumption, 
teeth grinding while sleeping, gum chewing 
(hours per day), and past chelation therapy.
Urine and hair specimens. Each subject 
provided a spot urine sample in a mercury-
free container (Vacutainer Urine Collection 
Cup; Becton Dickinson, Franklin Lakes, NJ). 
A mini  mum of 10 mg of hair (~ 10–20 hair 
strands) was collected from the occipital 
region of the head. We were not able to obtain 
urine from 13 subjects and hair samples from 
10 subjects. 
Total mercury content in urine and hair 
(first 2 cm of hair closest to the scalp) sam-
ples was determined using atomic absorption 
spectroscopy (Direct Mercury Analyzer-80; 
Milestone Inc., Shelton, CT) based on 
U.S. Environmental Protection Agency 
(EPA) Method 7473, as described elsewhere 
(Goodrich et al. 2011). No hair or urine sam-
ples were below the theoretical method detec-
tion limit (urine: 2009, 0.05 ng; 2010, 0.01 ng; 
hair: 2009, 0.07 ng; 2010, 0.01 ng), calculated 
as three times the standard deviation of blank 
measure  ments. We measured specific gravity 
of urine samples to account for the variability 
of metal excretion associated with spot urine 
samples (Mason and Calder 1994). Creatinine 
was not measured (Heyer et al. 2007).
SNP selection and genotyping. Buccal 
swabs were used to collect DNA samples 
(Goodrich et al. 2011). Genomic DNA was 
isolated and purified for genotyping using 
the Wizard SV Genomic DNA Purification 
System (Promega, Madison, WI).
Thirteen MT SNPs were selected in regions 
that were important for gene expression or were 
hypothesized to regulate the structure and/or 
folding of the MT proteins (e.g., exon coding 
regions) (Table 1). SNPs in these regions 
might lead to alterations in mercury-binding 
capacity, subsequently influencing biomarker 
levels. Thus, we included mis  sense SNPs with 
relatively high prevalence in the coding regions 
and SNPs located in regions important for 
mRNA transcription, including the 5´ flanking 
region of the sequences (Aschner 1996), the 
metal-responsive elements (MREs) in the 
upstream promoter region (Karin et al. 1987a), 
and the 3´ untranslated region (3´ UTR) 
(Hesketh 2004). The availability and use of 
transcription inducers, such as metal-regulatory 
transcription factor-1 (MTF-1), are important 
for MT expression, and SNPs in MTF1 were 
also geno  typed (Karin et al. 1987b; Palmiter 
1994). All selected SNPs had minor allele 
frequencies ≥ 5% in the Centre d’Etude du 
Polymorphisme Humain panel (Dausset 
et al. 1990), and all were in Hardy-Weinberg 
equilibrium. Not all SNPs were geno  typed in 
subjects from both sampling years (Table 1).
We used TaqMan allelic discrimina-
tion assays (Applied Biosystems, Foster City, 
CA) to geno  type all SNPs except MT1A 
(rs8052394), and results were read on a 7300 
Real-time PCR (polymerase chain reaction) 
System (Life Technologies Corp., Carlsbad, 
CA). The restriction fragment length poly-
morphism (RFLP) method was used to geno-
type MT1A (rs8052394).
Statistical methods. All statistical analyses 
were performed using SAS software (version 
9.2; SAS Institute Inc., Cary, NC). In all analy-
ses, we excluded four subjects who reported 
chelation therapy in the last 6 months. Eight 
subjects who reported a history of pre  existing 
kidney disease (lithiasis, pyelo  nephritis, ortho-
static proteinuria, end-stage kidney disease, 
or chronic renal failure) were excluded from 
all analyses of urine mercury. In our sample, 
dentists had a higher mean urine mercury level 
(1.40 μg/L) than did hygienists (0.64 μg/L) 
or assistants (0.96 μg/L). To investigate the 
hypothesis and ensure coherence in discussion, 
we investigated MT SNP effect modification 
in dentists, the sub  population with the high-
est elemental mercury exposure, assuming the 
same toxico  kinetics in dentists, hygienists, and 
assistants. A dichotomous variable with dentist 
being the referent, as opposed to non  dentist 
(hygienist, assistant, and other), was thus used 
in the analyses.
Descriptive analyses were performed on 
body mass index (BMI), age, occupation, and 
race (Caucasian and non-Caucasian) along 
with mercury exposure levels reflected in uri-
nary and hair mercury biomarkers and expo-
sure surrogate variables (e.g., amalgams, fish 
consumption). Bivariate analyses included 
race- and occupation-stratified analyses of BMI 
and age, exposure-stratified urinary and hair 
mercury levels, and SNP-geno  type–stratified 
urinary and hair mercury levels. Multivariate 
regression analyses were conducted in two 
phases for log-transformed urine and hair mer-
cury levels because both urinary and hair mer-
cury levels were not normally distributed. We 
fitted urine regression models with unadjusted 
mercury levels and with those adjusted for 
specific gravity (1.017). Parameter estimates 
did not notably change, and corresponding 
significance changed in only a few instances in 
specific-gravity–adjusted models. Unadjusted 
models are reported here unless otherwise 
noted (Heyer et al. 2007).
In the first phase, using multi  variate 
linear regression models, natural log (ln)-
transformed urinary and hair mercury were 
regressed separately against number of 
personal amalgams (linear continuous) and 
number of amalgams handled per week 
[ordinal; see categories in Supplemental 
Table 1. Selected MT SNPs genotyped in 2009 and 2010.
3´ UTR Missense MRE proximity (5´ near)
MT2A MT1M MT1M MT1G MT1E MT1A MT1M MT4 MT1A MT2A MT1A MTF1
dbSNP no. rs10636 rs9936741 rs2270837 rs12315 rs708274 rs11640851 rs1827210 rs11643815 rs8052394 rs28366003 rs9922957 rs473279 rs3748682
Major allele G T G G G A A G A A C G T
Allele variant C C A T T C C A G G G A C
Minor allele frequency 0.299 0.020 0.153 0.048 0.126 0.344 0.157 0.136 0.095 0.062 0.127 0.334 0.244
Genotype year
2009 only X X X X X
2010 only X X X
2009–2010 X X X     X           XWang et al.
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Material, Table 2 (http://dx.doi.org/10.1289/
ehp.1104079)] and estimated daily MeHg 
intake from fish (linear continuous). In 
the regression models, the covariates gum 
chewing, teeth grinding, occupation, age, 
race, BMI, sex, and alcohol consumption 
were all added to both urine and hair models. 
A base model was selected separately for each 
biomarker using backward elimination starting 
from the model that included all exposure 
terms and covariates. The least statistically 
significant predictor was eliminated in each 
step, and the final base models for urine and 
hair mercury were derived by retaining all 
significant predictors (p < 0.05). Sex was 
forced into both final models to assess the 
potential confounding of sex with occupation 
because most of the non  dentists (94.8%) 
were female. We fitted each base model with 
a dentist-only or a nondentist-only sample; 
sex was not significant in the dentist-only 
sample, meaning the significance of sex was 
due to confounding with occupation. Thus, 
we excluded sex in the final base models. In 
the second phase, we created two dummy 
variables for each SNP: hetero  zygote (major 
homo  zygote as referent) and homo  zygote 
variant (major homo  zygote as referent). The 
base models of urinary and hair mercury 
were combined with main effect and inter-
action terms between the respective exposure 
predictors and dummy variables of each SNP. 
Interactions between exposure and geno  type 
were investigated one SNP at a time.
Results
Demographics, exposure surrogates, and bio-
markers. The total sample included 515 par-
ticipants and was predominantly Caucasian 
(90.5%). Dentists comprised 47.4% of the 
sample, and most of the non  dentists were 
female (Table 2). Mean age differed sig-
nificantly within both race and occupation 
categories. The mean numbers of amalgams 
handled per week and personal amalgams 
were 25.5 and 4.1, respectively. The mean 
estimated daily MeHg intake from fish was 
0.084 μg/kg/day (range, 0–0.98 μg/kg/day), 
with 25% of study population intakes exceed-
ing the current U.S. EPA reference dose of 
0.1 μg/kg/day (U.S. EPA 2001). 
The mean levels and distribution of urine 
and hair mercury seen in our study were simi-
lar to those in the U.S. general population 
(Table 3) because no significant difference 
was found in geometric and arithmetic mean 
mercury levels in urine or hair in our study 
population compared with reference levels 
reported for NHANES 2003–2004 (CDC 
2009) and NHANES 1999–2000 (McDowell 
et al. 2004), respectively. Mean urinary mer-
cury levels showed a linear trend of increase 
as exposure increased from occupational 
handling of amalgam and personal amalgam 
[see Supplemental Material, Table 2 (http://
dx.doi.org/10.1289/ehp.1104079)]. Similarly, 
hair mercury levels increased linearly with 
MeHg intake from dietary fish consumption 
(see Supplemental Material, Table 3).
Associations between SNPs and biomarker 
levels with and without adjustment for expo-
sure. Mean urine and hair mercury levels were 
compared among SNP geno  types with no 
adjustment for amalgam exposure or dietary 
MeHg intake, respectively. We observed 
no significant differences for any geno  type 
[see Supplemental Material, Table 4 (http://
dx.doi.org/10.1289/ehp.1104079)].
In the base urine model, number of per-
sonal amalgams and number of amalgams 
handled per week predict ln-transformed uri-
nary mercury with adjustment for occupation. 
Occupational mercury exposure explains only 
approximately 10% of the total variance of the 
multi  variate model, compared with > 60% for 
exposure from personal amalgams. We added 
SNP main effect and inter  action terms to 
each base model. Statistically significant inter-
actions were observed for MT1M (rs2270837) 
(Table 4) and MT2A (rs10636), although the 
latter (homo  zygote variant CC interacting 
with personal amalgam exposure; β = 0.06) 
was observed only when urine was adjusted for 
specific gravity. Compared with the MT1M 
(rs2270837) homo  zygote geno  type GG, sub-
jects with homo  zygote variant geno  type AA 
had lower urinary mercury levels [Table 4; see 
Supplemental Material, Figure 1a,b (http://
dx.doi.org/10.1289/ehp.1104079)].
In the hair mercury base model, estimated 
daily MeHg intake from fish predicted ln-
transformed hair mercury after adjusting for 
occupation and age. In the subsequent analy-
ses, only estimated daily MeHg intake was used 
as a predictor because we sought to investigate 
the effect modification of SNPs on estimated 
daily MeHg intake and to simplify interpreta-
tion. We then added SNP main effect and 
inter  action terms to each base model. For all 
SNPs except MT1A (rs8052394) and MT1M 
(rs9936741), there were no significant inter-
action terms. Compared with homo  zygote 
MT1M (rs9936741; TT), after controlling 
for MeHg intake, subjects with hetero  zygote 
TC geno  type had higher hair mercury levels 
[Table 5; see Supplemental Material, Figure 1c 
(http://dx.doi.org/10.1289/ehp.1104079)]. 
Those with MT1A (rs8052394) hetero  zygote 
GA and homo  zygote variant GG geno  types 
had lower hair mercury levels than did those 
with homo  zygote AA geno  type (Table 5; see 
Supplemental Material, Figure 1d).
Discussion
We found significant effect modification of 
MT1M (rs2270837) homo  zygote variant 
AA geno  type on the relationship of urinary 
mercury level with both occupational and 
personal exposures to elemental mercury 
after adjusting for covariates. We also found 
significant effect modification of MT2A 
(rs10636) CC geno  type on the relationship 
between urinary mercury level and personal 
Table 2. Demographics.
Characteristic n Age [years (mean ± SD)] BMI [kg/m2 (mean ± SD)] Female [n (%)]
Occupation
Dentist 244 56.1 ± 11.6* 26.4 ± 4.0 60 (24.6)
Non  dentist 269 48.2 ± 11.2* 26.4 ± 5.3 255 (94.8)
Subtotal 513 315 (61.4)
Missing 2
Race
Caucasian 463 52.5 ± 11.9** 26.3 ± 4.6
Non-Caucasian 49 46.8 ± 12.5** 27.1 ± 6.1
Subtotal 512
Missing 3      
*p < 0.005. **p < 0.0001. 
Table 3. Urine mercury (μg/L) and hair mercury (μg/g) in the Michigan Dental Association (MDA) mercury 
study compared with reference levels from NHANES (2003–2004) and NHANES (1999–2000), respectively.
Geometric 
mean
Arithmetic 
meana
Percentile
Biomarker, study  50th 75th 90th 95th
Urine mercury 
NHANES 2003–2004 (n = 1,529) 0.50# 0.95 0.48 1.12 2.20 3.33
MDA study
2009 (n = 229) 0.69## 1.11 0.72 1.37 2.51 3.37
2010 (n = 273) 0.62## 1.02 0.62 1.19 2.15 3.74
2009–2010 (n = 502) 0.65# 1.06 0.66 1.29 2.34 3.37
Hair mercury 
NHANES 1999–2000 (n = 1,726) 0.12* 0.47 0.19 0.42 1.11 1.73
MDA study
2009 (n = 226) 0.30** 0.55 0.29 0.66 1.36 1.92
2010 (n = 279) 0.27** 0.45 0.28 0.54 1.07 1.33
2009–2010 (n = 505) 0.28* 0.51 0.29 0.58 1.17 1.49
aUrine arithmetic mean was calculated using NHANES (2003–2004) data. *p = 0.29. **p = 0.90. #p = 0.19. ##p = 0.77. Metallothionein SNP effects on mercury biomarker
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exposure to elemental mercury. We found 
significant effect modification of MT1M 
(rs9936471) heterozygous TC geno  type, 
and MT1A (rs8052394) pooled hetero  zygote 
GA and homo  zygote variant GG geno-
types on the relationship of hair mercury 
level with estimated daily MeHg intake 
from fish consumption. No significant effect 
modification was found from other MT SNPs.
The mean urinary mercury levels observed 
in our study population (dentists, 1.37 μg/L; 
hygienists and assistants, 0.75 μg/L) were lower 
than those in some previous reports for both 
occupationally and non  occupationally exposed 
populations (dentists, 2.50–3.32 μg/L; dental 
assistants, 1.60–1.98 μg/L) (DeRouen et al. 
2006; Echeverria et al. 2005,2006; Factor-
Litvak et al. 2003; Heyer et al. 2008). The 
relatively low hair mercury levels and estimated 
mean daily MeHg intake from fish were con-
sistent with what has been reported in North 
American non  indigenous populations in a 
number of studies (0.068 ± 0.109 μg/kg/day) 
(Canuel et al. 2006; Mahaffey et al. 2004). In 
our study, where occupation was a predictor of 
hair mercury level, it may be that occupation 
was a surrogate of socio  economic status (SES), 
because dentists fall into a higher SES group 
and were more likely to eat fish than were non-
dentists. Increasing age has been shown to be 
associated with increasing MeHg level in blood 
(Schläwicke Engström et al. 2008) and may 
also be a reflection of deterioration of mercury 
metabolism and elimination.
Prior epidemiological literature on the 
studied MT SNPs and their relationship with 
mercury exposure is scarce. Gundacker et al. 
(2009) reported findings of effect modifica-
tions of MT4 (rs11643815) on the exposure–
biomarker relationship for mercury in hair but 
not in urine. Unlike Gundacker et al. (2009), 
we did not assume that all fish have the same 
level of mercury. We did not find any effect 
modification of MT4, which differs from the 
finding of Gundacker et al. (2009). This may 
be the result of using species-specific fish mer-
cury levels in our calculation of estimated daily 
MeHg intake, which is likely a better estima-
tion than total fish meals used in their study.
Here we studied several other MT SNPs 
hypothesized to be potentially important for 
their relationship with mercury exposure, 
some of which showed significant inter  actions 
with the exposure–biomarker relationship. We 
found the exon-coding MT1A (rs8052394) to 
modify the relationship of MeHg intake with 
hair mercury. MT1A isoforms are functional 
(West et al. 1990), but knowledge of the 
impact of the various SNPs, including MT1A 
(rs8052394), on structural/folding changes 
and the resulting impact on protein function-
ality and ability to bind mercury is limited.
Differential findings of the effects of 
the SNPs on elemental-mercury–biomarker 
(urine) and MeHg–biomarker (hair) relation-
ships are not surprising given that the binding 
of heavy metals varies depending on the 
molecular structures and redox chemistry 
of MT proteins (Krezel and Maret 2007). 
Notably, we did not observe the positive effect 
modification of MT1M (rs2270837) on urine 
mercury in the hair mercury model, and vice 
versa for MT1M (rs9936741). Prior evidence 
of MT1M SNP functionality is lacking 
because the MT1M isoform has only recently 
been found to be functional (Lin et al. 2009; 
Michael et al. 2011; Oliveira et al. 2011). 
Hence, the significance of these associations is 
uncertain. Although other isoforms, including 
MT2A, MT1E, and MT1G, are also 
functional (West et al. 1990), their ability to 
bind heavy metals, as with the MT1A isoform, 
depends on several factors: MT abundance in 
target tissues, mercury form in target tissues, 
and redox chemis  try of MT and thiolate 
(Maret and Vallee 1998). Inorganic mercury 
and MeHg differ in their target organs (kidney 
vs. brain) and elimination routes (urine vs. 
feces). Thus, levels of MT vary across the 
target tissues, which may contribute to the 
differential modifications. Overall, the under-
lying mechanism(s) for the observed significant 
inter  actions with exposure–biomarker relation-
ship is unclear and requires further study.
The present study has a number of 
limitations. First, the study has a relatively 
small sample size. For some SNPs [e.g., 
MT1M (rs2270837)], < 15 subjects had the 
homo  zygous variant geno  type. The small 
numbers limit the power to assess effects of 
gene–gene interactions on exposure–biomarker 
relationships. Second, it was difficult to rule out 
the possibility of false positives due to multiple 
comparisons. Of the 51 comparisons made 
in the urine models, only 2 were statistically 
significant [see Supplemental Material, Table 5 
(http://dx.doi.org/10.1289/ehp.1104079)]; 2 of 
19 comparisons made in the hair models were 
signifi  cant (see Supplemental Material, Table 6). 
Third, our study group was a convenience 
sample, not a random sample. However, there 
is no reason to believe that subjects had any 
prior knowledge of their geno  types or mercury 
levels. Thus, there was a low probability 
of selection bias. Fourth, instead of using 
total amalgam surfaces, a more refined and 
potentially more accurate surrogate for personal 
exposure to elemental mercury, we used the 
total number of amalgam restorations. Despite 
this, the total number of personal amalgams 
was still found to be the most significant 
predictor for ln-transformed urinary mercury 
levels. Fifth, the choice of deriving daily MeHg 
intake from the NHANES Food Frequency 
Table 5. Coefficients and p-values from multi  variate linear regression models of ln-transformed hair mer-
cury predicted by estimated MeHg exposure, SNP genotype, and intake–SNP interactions.
MT1M 3´ UTR (T > C; 
rs9936741; R2 = 0.20)
MT1A missense (A > G; 
rs8052394; R2 = 0.21)
β-Coefficient p-Value β-Coefficient p-Value
Base model
Estimated daily MeHg intake 3.69 < 0.0001 4.04 < 0.0001
SNP main effects
Heterozygote –0.03 0.92 0.21 0.40
Homozygote variant —a —a —b —b
SNP–intake interactions
Intake × heterozygote 19.3 0.02 –300 0.02
Intake × homozygote variant —a —a —b —b
aThe homozygote variant number was zero for MT1M (rs9936741). bBecause the number of homozygote variants for 
MT1A (rs8052395) was too small (n = 1), it was lumped with the heterozygote variant in testing interaction.
Table 4. Coefficients and p-values of multi  variate linear regression models of ln-transformed urinary 
mercury predicted against exposure surrogates of elemental mercury, MT1M [3´ UTR (G > A); rs2270837] 
geno  type, and exposure–MT1M interactions.
Exposure β-Coefficient p-Value
Base model (R2 = 0.25)
Intercept –0.70
Personal amalgams 0.085 < 0.0001
Amalgams handled/week 0.11 0.04
Nondentist –0.38 0.001
SNP main effects
Heterozygote –0.04 0.87
Homozygote variant 1.85 0.008
SNP–exposure interaction
Personal amalgams × heterozygote –0.002 0.92
Amalgams handled × heterozygote 0.11 0.32
Nondentist × heterozygote –0.03 0.90
Personal amalgams × homozygote variant –0.25 0.02
Amalgams handled × homozygote variant –0.97 0.01
Nondentist × homozygote variant –0.06 0.94Wang et al.
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Questionnaire (2003–2004; CDC 2004) and 
species-specific mercury levels may create recall 
and mis  classi  fica  tion biases. Despite similar bias 
in self-reporting recent exposure to elemental 
mercury, our findings on the relationship 
between urinary mercury levels and exposures 
from personal amalgams and dental practice 
were consistent with the results of previous 
reports. Sixth, mercury measurements in 2 cm 
of hair closest to the scalp reflect only the most 
recent 2 months of MeHg exposure from fish. 
The question  naire examined fish consumption 
during the 6 months before the survey, and an 
unbiased reflection of fish MeHg intake in hair 
mercury was dependent upon a steady-state 
body burden of MeHg. The fish consumption 
of subjects may have fluctuated in the months 
prior to the survey. However, such fluctuation 
would likely bias the study results toward 
the null because a subject’s fish consumption 
may either increase or decrease during the 
2–6 months before the survey. Seventh, day-to-
day variability in urinary mercury excretion has 
been reported to average 22% among samples 
taken on three consecutive days (Ellingsen et al. 
1993). However, this magnitude of variation is 
modest, and the likely impact would be to bias 
the results toward the null. Despite the study 
limitations, this is the largest gene–environment 
study investigating the potential impact of MT 
SNPs in humans on the relationship between 
mercury biomarkers and exposure to both 
elemental mercury and MeHg.
Conclusion
We observed significant effect modifications of 
MT SNPs on biomarker–exposure associations 
for both elemental mercury and MeHg. 
Our study is the first to report significant 
effect modification of selected MT SNPs 
on the relationship of urinary mercury with 
occupational and non  occupational exposures. 
We used a more precise survey methodology 
for estimating individual daily MeHg intake 
from fish based on the NHANES Food 
Frequency Questionnaire (2003–2004; 
CDC 2004) and species-specific mercury 
levels. The effect modifications of some MT 
SNPs appear to differ on the basis of mercury 
forms, although the exact mechanism is 
unclear. Thus, our findings contribute to a 
small body of previous research on MT SNPs 
involved in modifying the mercury exposure–
biomarker relationship in humans, and also 
form a basis for future work in the field of 
gene–environment interactions concerning 
mercury. The ultimate goal is to improve our 
understanding of mercury biomarkers and the 
overall risk assessment of mercury exposure. 
Future studies are warranted to replicate the 
effect modification results of the SNPs and to 
assess the potential mechanisms under  lying the 
effect modifications (e.g., altered expression). 
Future work may also examine gene–gene 
interactions (e.g., GST) with MT SNPs on the 
exposure–biomarker (e.g., blood) relationship 
in a larger sample. Although this study focused 
on dental professionals, the findings are 
relevant to the U.S. general population.
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NOTE: Wang et al. have reported an error in their article, “An Investigation of Modifying Effects of Metallothionein Single-Nucleotide 
Polymorphisms on the Association between Mercury Exposure and Biomarker Levels” [Environ Health Perspect 120:530–534 (2012)]. 
Throughout the article, the SNP labeled “rs2270836” should have been “rs2270837.” This does not alter any conclusions of their paper.
The authors regret the error.
The error has been corrected in the PDF version of this article.